Quality control of postoperative radiotherapy for non-small cell lung cancer: A study of mediastinal shift

IF 1.5 4区 医学 Q4 ONCOLOGY Cancer Radiotherapie Pub Date : 2024-04-01 DOI:10.1016/j.canrad.2023.06.032
W. Zhang , Y. Zhang , W.-W. Ouyang , S. Fa Su , Z. Ma , Q.-S. Li , W. Gang Yang , X. Xia Chen , J. Liu , B. Lu
{"title":"Quality control of postoperative radiotherapy for non-small cell lung cancer: A study of mediastinal shift","authors":"W. Zhang ,&nbsp;Y. Zhang ,&nbsp;W.-W. Ouyang ,&nbsp;S. Fa Su ,&nbsp;Z. Ma ,&nbsp;Q.-S. Li ,&nbsp;W. Gang Yang ,&nbsp;X. Xia Chen ,&nbsp;J. Liu ,&nbsp;B. Lu","doi":"10.1016/j.canrad.2023.06.032","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>This study aimed to assess the shifting patterns of the mediastinum, including the target volume and the isocenter point during the postoperative radiotherapy (PORT) process of non-small cell lung cancer (NSCLC), and to observe the occurrence of radiation injury. Additionally, we investigated the significance of mid-term assessment during the implementation of the PORT process.</p></div><div><h3>Material and methods</h3><p>We established coordinate axes based on bone anatomy and measured the mediastinum's three-dimensional direction and the shift of the isocenter point's shift in the PORT process. Statistical analysis was performed using Wilcoxon, Kruskal-Wallis, and the Chi-square test. <em>P</em> <!-->&lt;<!--> <!-->0.05 was considered statistically significant.</p></div><div><h3>Results</h3><p>In this study, the analysis of patients revealed that the shift of anterior and posterior mediastinum (X), left and right mediastinum (Y), upper and lower mediastinum (Z), anterior and posterior isocenter point (X<sub>i</sub>), and the left and right isocenter points (Y<sub>i</sub>) in the PORT process were 0.04–0.53, 0.00–0.84, 0.00–1.27, 0.01–0.86, and 0.00–0.66<!--> <!-->cm, respectively. The shift distance of the mediastinum was Z<!--> <!-->&gt;<!--> <!-->Y<!--> <!-->&gt;<!--> <!-->X, and the shift distance of the isocenter point was X<sub>i</sub> <!-->&gt;<!--> <!-->Y<sub>i</sub>. According to the ROC curve, the cut-off values were 0.263, 0.352, 0.405, 0.238, and 0.258, respectively, which were more significant than the cut-off values in 25 cases (25%), 30 cases (30%), 30 cases (30%), 17 cases (17%), and 15 cases (15%). In addition, there was a significant difference in the shift of the mediastinum and the isocenter point (all <em>P</em> <!-->=<!--> <!-->0.00). Kruskal-Wallis test showed no statistically significant difference between mediastinal shift and resection site in X, Y, and Z directions (<em>P</em> <!-->=<!--> <!-->0.355, <em>P</em> <!-->=<!--> <!-->0.239, <em>P</em> <!-->=<!--> <!-->0.256), surgical method (<em>P</em> <!-->=<!--> <!-->0.241, <em>P</em> <!-->=<!--> <!-->0.110, <em>P</em> <!-->=<!--> <!-->0.064). There was no significant difference in the incidence of RE and RP in PORT patients (<em>P</em> <!-->&gt;<!--> <!-->0.05). No III–IV RP occurred. However, the incidence of ≥ grade III RE in the modified plan cases after M-S was significantly lower than in the original PORT patients, 0% and 7%, respectively (<em>P</em> <!-->=<!--> <!-->0.000).</p></div><div><h3>Conclusion</h3><p>In conclusion, this study provides evidence that mediastinal shift is a potential complication during the PORT process for patients with N2 stage or R1–2 resection following radical resection of NSCLC. This shift affects about 20–30% of patients, manifesting as actual radiation damage to normal tissue and reducing the local control rate. Therefore, mid-term repositioning of the PORT and revision of the target volume and radiation therapy plan can aid in maintaining QA and QC during the treatment of NSCLC patients and may result in improved patient outcomes.</p></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"28 2","pages":"Pages 152-158"},"PeriodicalIF":1.5000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Radiotherapie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1278321823002457","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose

This study aimed to assess the shifting patterns of the mediastinum, including the target volume and the isocenter point during the postoperative radiotherapy (PORT) process of non-small cell lung cancer (NSCLC), and to observe the occurrence of radiation injury. Additionally, we investigated the significance of mid-term assessment during the implementation of the PORT process.

Material and methods

We established coordinate axes based on bone anatomy and measured the mediastinum's three-dimensional direction and the shift of the isocenter point's shift in the PORT process. Statistical analysis was performed using Wilcoxon, Kruskal-Wallis, and the Chi-square test. P < 0.05 was considered statistically significant.

Results

In this study, the analysis of patients revealed that the shift of anterior and posterior mediastinum (X), left and right mediastinum (Y), upper and lower mediastinum (Z), anterior and posterior isocenter point (Xi), and the left and right isocenter points (Yi) in the PORT process were 0.04–0.53, 0.00–0.84, 0.00–1.27, 0.01–0.86, and 0.00–0.66 cm, respectively. The shift distance of the mediastinum was Z > Y > X, and the shift distance of the isocenter point was Xi > Yi. According to the ROC curve, the cut-off values were 0.263, 0.352, 0.405, 0.238, and 0.258, respectively, which were more significant than the cut-off values in 25 cases (25%), 30 cases (30%), 30 cases (30%), 17 cases (17%), and 15 cases (15%). In addition, there was a significant difference in the shift of the mediastinum and the isocenter point (all P = 0.00). Kruskal-Wallis test showed no statistically significant difference between mediastinal shift and resection site in X, Y, and Z directions (P = 0.355, P = 0.239, P = 0.256), surgical method (P = 0.241, P = 0.110, P = 0.064). There was no significant difference in the incidence of RE and RP in PORT patients (P > 0.05). No III–IV RP occurred. However, the incidence of ≥ grade III RE in the modified plan cases after M-S was significantly lower than in the original PORT patients, 0% and 7%, respectively (P = 0.000).

Conclusion

In conclusion, this study provides evidence that mediastinal shift is a potential complication during the PORT process for patients with N2 stage or R1–2 resection following radical resection of NSCLC. This shift affects about 20–30% of patients, manifesting as actual radiation damage to normal tissue and reducing the local control rate. Therefore, mid-term repositioning of the PORT and revision of the target volume and radiation therapy plan can aid in maintaining QA and QC during the treatment of NSCLC patients and may result in improved patient outcomes.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
非小细胞肺癌术后放疗的质量控制:纵隔转移研究
目的:本研究旨在评估非小细胞肺癌(NSCLC)术后放疗(PORT)过程中纵隔的移动模式,包括靶体积和等中心点,并观察放射损伤的发生情况。此外,我们还研究了在实施 PORT 过程中进行中期评估的意义:我们根据骨解剖学建立了坐标轴,并测量了纵隔的三维方向和等中心点在 PORT 过程中的移动。采用 Wilcoxon、Kruskal-Wallis 和卡方检验进行统计分析。结果本研究对患者的分析显示,PORT 过程中前后纵隔(X)、左右纵隔(Y)、上下纵隔(Z)、前后等中心点(Xi)和左右等中心点(Yi)的移位分别为 0.04-0.53、0.00-0.84、0.00-1.27、0.01-0.86 和 0.00-0.66cm。纵隔移位距离为 Z>Y>X,等中心点移位距离为 Xi>Yi。根据 ROC 曲线,临界值分别为 0.263、0.352、0.405、0.238 和 0.258,分别比 25 例(25%)、30 例(30%)、30 例(30%)、17 例(17%)和 15 例(15%)的临界值显著。此外,纵隔和等中心点的移位也存在明显差异(均为 P=0.00)。Kruskal-Wallis检验显示,纵隔移位与切除部位在X、Y、Z方向(P=0.355、P=0.239、P=0.256)、手术方式(P=0.241、P=0.110、P=0.064)上差异无统计学意义。PORT患者的RE和RP发生率无明显差异(P>0.05)。没有发生Ⅲ-Ⅳ度 RP。然而,M-S后的改良计划病例中≥Ⅲ级RE的发生率明显低于原始PORT患者,分别为0%和7%(P=0.000):总之,本研究提供的证据表明,纵隔移位是NSCLC根治性切除术后N2期或R1-2切除术患者在PORT过程中可能出现的并发症。约有 20%-30% 的患者会受到这种移位的影响,表现为对正常组织的实际辐射损伤,并降低局部控制率。因此,在治疗 NSCLC 患者的过程中,中期重新定位 PORT 并修改靶体积和放疗计划有助于保持质量保证和质量控制,从而改善患者的预后。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Cancer Radiotherapie
Cancer Radiotherapie 医学-核医学
CiteScore
2.20
自引率
23.10%
发文量
129
审稿时长
63 days
期刊介绍: Cancer/radiothérapie se veut d''abord et avant tout un organe francophone de publication des travaux de recherche en radiothérapie. La revue a pour objectif de diffuser les informations majeures sur les travaux de recherche en cancérologie et tout ce qui touche de près ou de loin au traitement du cancer par les radiations : technologie, radiophysique, radiobiologie et radiothérapie clinique.
期刊最新文献
Long-term cardiac mortality in patients treated with radiation for gastric mucosa-associated lymphoid tissue lymphoma Dose comparison between hybrid volumetric modulated arc therapy, volumetric modulated arc therapy, and three-dimensional conformal radiotherapy for breast/chest wall irradiation, including regional lymph node irradiation using deep inspiration breath-hold technique Cyberneo trial investigating the efficacy of stereotactic radiotherapy combined to neoadjuvant chemotherapy for locally advanced breast cancer: 14-years follow-up results Exploring treatment complexity in maxillary ameloblastoma: A case study on the efficacy of radiotherapy with transcriptomic and literature insights Does prior radiotherapy impact the acute cellular liver graft rejection?
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1